Moroctocog alfa

Trade Name: 
Xyntha
Manufacturer/Distributor: 
Wyeth-Pfizer Canada
Classification: 
Hemostatic agent
ATC Class: 
B02BD02 - Coagulation Factor VIII
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2008/04/23
Date Marketed in Canada (yyyy/mm/dd): 
2009/01/23
Presentation: 
IV powder for solution: 250 IU. DIN: 02309483
IV powder for solution: 500 IU. DIN: 02309491
IV powder for solution: 1000 IU. DIN: 02309505
IV powder for solution: 2000 IU. DIN: 02309513
Comments: 
For prevention of hemorrhagic episodes and for routine and surgical prophylaxis in patients with hemophilia A.